Alpha 2.0

» Articles » PMID: 26357491

Nuclear Molecular Imaging for Vulnerable Atherosclerotic Plaques

Overview

Overview

Journal Korean J Radiol

Specialty Radiology

Date 2015 Sep 11

PMID 26357491

Citations 6

Authors

Authors

Soo Jin Lee

Jin Chul Paeng

Affiliations

Affiliations

Soon will be listed here.

Abstract

Atherosclerosis is an inflammatory disease as well as a lipid disorder. Atherosclerotic plaque formed in vessel walls may cause ischemia, and the rupture of vulnerable plaque may result in fatal events, like myocardial infarction or stroke. Because morphological imaging has limitations in diagnosing vulnerable plaque, molecular imaging has been developed, in particular, the use of nuclear imaging probes. Molecular imaging targets various aspects of vulnerable plaque, such as inflammatory cell accumulation, endothelial activation, proteolysis, neoangiogenesis, hypoxia, apoptosis, and calcification. Many preclinical and clinical studies have been conducted with various imaging probes and some of them have exhibited promising results. Despite some limitations in imaging technology, molecular imaging is expected to be used both in the research and clinical fields as imaging instruments become more advanced.

Citing Articles

Molecular Imaging of Vulnerable Coronary Plaque with Radiolabeled Somatostatin Receptors (SSTR).

Anzola L, Rivera J, Ramirez J, Signore A, Mut F J Clin Med. 2021; 10(23).

PMID: 34884218 PMC: 8658082. DOI: 10.3390/jcm10235515.

Molecular Imaging and Non-molecular Imaging of Atherosclerotic Plaque Thrombosis.

Guo B, Li Z, Tu P, Tang H, Tu Y Front Cardiovasc Med. 2021; 8:692915.

PMID: 34291095 PMC: 8286992. DOI: 10.3389/fcvm.2021.692915.

Non-oncological applications of RGD-based single-photon emission tomography and positron emission tomography agents.

Ebenhan T, Kleynhans J, Zeevaart J, Jeong J, Sathekge M Eur J Nucl Med Mol Imaging. 2020; 48(5):1414-1433.

PMID: 32918574 DOI: 10.1007/s00259-020-04975-9.

Measurement of Ga-DOTATOC Uptake in the Thoracic Aorta and Its Correlation with Cardiovascular Risk.

Lee R, Kim J, Paeng J, Byun J, Cheon G, Lee D Nucl Med Mol Imaging. 2018; 52(4):279-286.

PMID: 30100940 PMC: 6066488. DOI: 10.1007/s13139-018-0524-y.

SPECT and PET imaging of angiogenesis and arteriogenesis in pre-clinical models of myocardial ischemia and peripheral vascular disease.

Hendrikx G, Voo S, Bauwens M, Post M, Mottaghy F Eur J Nucl Med Mol Imaging. 2016; 43(13):2433-2447.

PMID: 27517840 PMC: 5095166. DOI: 10.1007/s00259-016-3480-8.

References

1.

Beer A, Pelisek J, Heider P, Saraste A, Reeps C, Metz S . PET/CT imaging of integrin αvβ3 expression in human carotid atherosclerosis. JACC Cardiovasc Imaging. 2014; 7(2):178-87. DOI: 10.1016/j.jcmg.2013.12.003. View

2.

Laitinen I, Saraste A, Weidl E, Poethko T, Weber A, Nekolla S . Evaluation of alphavbeta3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice. Circ Cardiovasc Imaging. 2009; 2(4):331-8. DOI: 10.1161/CIRCIMAGING.108.846865. View

3.

Rudd J, Myers K, Bansilal S, Machac J, Woodward M, Fuster V . Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study. Circ Cardiovasc Imaging. 2009; 2(2):107-15. PMC: 3190196. DOI: 10.1161/CIRCIMAGING.108.811752. View

4.

Derlin T, Toth Z, Papp L, Wisotzki C, Apostolova I, Habermann C . Correlation of inflammation assessed by 18F-FDG PET, active mineral deposition assessed by 18F-fluoride PET, and vascular calcification in atherosclerotic plaque: a dual-tracer PET/CT study. J Nucl Med. 2011; 52(7):1020-7. DOI: 10.2967/jnumed.111.087452. View

5.

Derlin T, Wisotzki C, Richter U, Apostolova I, Bannas P, Weber C . In vivo imaging of mineral deposition in carotid plaque using 18F-sodium fluoride PET/CT: correlation with atherogenic risk factors. J Nucl Med. 2011; 52(3):362-8. DOI: 10.2967/jnumed.110.081208. View

6.

Tepe G, Duda S, Meding J, Brehme U, Ritter J, Hanke H . Tc-99m-labeled endothelin derivative for imaging of experimentally induced atherosclerosis. Atherosclerosis. 2001; 157(2):383-92. DOI: 10.1016/s0021-9150(00)00753-x. View

7.

Rudd J, Myers K, Bansilal S, Machac J, Rafique A, Farkouh M . (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. J Am Coll Cardiol. 2007; 50(9):892-6. DOI: 10.1016/j.jacc.2007.05.024. View

8.

Mason D, Kenagy R, Hasenstab D, Bowen-Pope D, Seifert R, Coats S . Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery. Circ Res. 1999; 85(12):1179-85. DOI: 10.1161/01.res.85.12.1179. View

9.

Laitinen I, Marjamaki P, Nagren K, Laine V, Wilson I, Leppanen P . Uptake of inflammatory cell marker [11C]PK11195 into mouse atherosclerotic plaques. Eur J Nucl Med Mol Imaging. 2008; 36(1):73-80. DOI: 10.1007/s00259-008-0919-6. View

10.

Liu Y, Pierce R, Luehmann H, Sharp T, Welch M . PET imaging of chemokine receptors in vascular injury-accelerated atherosclerosis. J Nucl Med. 2013; 54(7):1135-41. PMC: 4251467. DOI: 10.2967/jnumed.112.114777. View

11.

Nakamura I, Hasegawa K, Wada Y, Hirase T, Node K, Watanabe Y . Detection of early stage atherosclerotic plaques using PET and CT fusion imaging targeting P-selectin in low density lipoprotein receptor-deficient mice. Biochem Biophys Res Commun. 2013; 433(1):47-51. DOI: 10.1016/j.bbrc.2013.02.069. View

12.

Muller H, Viaccoz A, Fisch L, Bonvin C, Lovblad K, Ratib O . 18FDG-PET-CT: an imaging biomarker of high-risk carotid plaques. Correlation to symptoms and microembolic signals. Stroke. 2014; 45(12):3561-6. DOI: 10.1161/STROKEAHA.114.006488. View

13.

Gaemperli O, Shalhoub J, Owen D, Lamare F, Johansson S, Fouladi N . Imaging intraplaque inflammation in carotid atherosclerosis with 11C-PK11195 positron emission tomography/computed tomography. Eur Heart J. 2011; 33(15):1902-10. DOI: 10.1093/eurheartj/ehr367. View

14.

Weis S, Cheresh D . Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med. 2011; 17(11):1359-70. DOI: 10.1038/nm.2537. View

15.

Bucerius J, Schmaljohann J, Bohm I, Palmedo H, Guhlke S, Tiemann K . Feasibility of 18F-fluoromethylcholine PET/CT for imaging of vessel wall alterations in humans--first results. Eur J Nucl Med Mol Imaging. 2008; 35(4):815-20. DOI: 10.1007/s00259-007-0685-x. View

16.

Rominger A, Saam T, Wolpers S, Cyran C, Schmidt M, Foerster S . 18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease. J Nucl Med. 2009; 50(10):1611-20. DOI: 10.2967/jnumed.109.065151. View

17.

Annovazzi A, Bonanno E, Arca M, DAlessandria C, Marcoccia A, Spagnoli L . 99mTc-interleukin-2 scintigraphy for the in vivo imaging of vulnerable atherosclerotic plaques. Eur J Nucl Med Mol Imaging. 2005; 33(2):117-26. DOI: 10.1007/s00259-005-1899-4. View

18.

Tavakoli S, Razavian M, Zhang J, Nie L, Marfatia R, Dobrucki L . Matrix metalloproteinase activation predicts amelioration of remodeling after dietary modification in injured arteries. Arterioscler Thromb Vasc Biol. 2010; 31(1):102-9. PMC: 3005135. DOI: 10.1161/ATVBAHA.110.216036. View

19.

Razavian M, Marfatia R, Mongue-Din H, Tavakoli S, Sinusas A, Zhang J . Integrin-targeted imaging of inflammation in vascular remodeling. Arterioscler Thromb Vasc Biol. 2011; 31(12):2820-6. PMC: 3228522. DOI: 10.1161/ATVBAHA.111.231654. View

20.

Mojtahedi A, Alavi A, Thamake S, Amerinia R, Ranganathan D, Tworowska I . Assessment of vulnerable atherosclerotic and fibrotic plaques in coronary arteries using (68)Ga-DOTATATE PET/CT. Am J Nucl Med Mol Imaging. 2015; 5(1):65-71. PMC: 4299775. View